Bought
Maintained
Sold
Other funds holding CME
INVST's CME Position: Q2 2026 in Review
INVST reduced its CME Group (CME) stake by 36% in Q2 2026, selling an estimated $264K and leaving 1,728 shares worth $382K. The position accounts for 0.04% of the portfolio, ranked #280.
INVST first reported a position in CME in Q3 2018 and has held it in 12 quarters since. The position peaked at $817K in Q1 2025. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- INVST held 1,728 shares of CME Group worth $382K as of Q2 2026.
- INVST sold 954 CME Group shares in Q2 2026, an estimated $264K.
- CME Group made up 0.04% of INVST's portfolio in Q2 2026, its #280 holding.
- INVST first reported a position in CME Group in Q3 2018 and has held it in 12 quarters since.
- INVST's CME Group position peaked at $817K in Q1 2025.
- 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on INVST's 13F filing for Q2 2026, filed 14 Aug 2026.